Pilot Study of the Human Metagenome in Metabolic Diseases

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
ObesitySarcopeniaSarcopenic ObesityChronic InflammationMetabolic Syndrome
Interventions
OTHER

No specific intervention

"Patient will undergo their routine clinical treatment for their related clinical condition (eg. anti-obesity or bariatric intervention for obese group; muscle strengthening interventions or necessary treatment for their concomitant medical condition for the sarcopenia group).~Follow-up testing will include repeat assessment of the subjects metagenome and metabolome over time, and after intervention~Control subjects will have no interventions performed as well."

Trial Locations (1)

544886

RECRUITING

Sengkang General Hospital, Singapore

All Listed Sponsors
collaborator

Singapore General Hospital

OTHER

collaborator

Lee Kong Chian School of Medicine, Nanyang Technological University

UNKNOWN

collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Sengkang General Hospital

OTHER